Samenvatting
Bij patiënten in de palliatieve fase kunnen door de ziekte en/of de behandeling veranderingen in de mond optreden. Deze veranderingen geven klachten die grote invloed kunnen hebben op de kwaliteit van leven. Ze kunnen leiden tot veranderingen in de voedingstoestand van de patiënt en problemen veroorzaken met intimiteit en sociale contacten.mondproblemen slikstoornissen palliatieve zorg
Literatuur Algemeen
Nieweg RMB. Mondproblemen bij chemotherapie: verandering van het mondslijmvlies. Verpleegkundige probleemgebieden: Diagnoses & Interventies 1995;1(12-1):1-30.
Sbanotto A. Oral complications of cancer. In: Ripamonti C, Bruera E. Gastrointestinal symptoms in advanced cancer patients. Oxford: Oxford University Press.; 2002. p. 81-113.
Swart EL, Waal I van der, Wilhelm AJ. Orale bijwerkingen van geneesmiddelen. Geneesmiddelenbulletin 2001;35:133-7.
Velthuizen L, Lugt-Lustig K de, Nieweg R. Mondverzorging: Anatomie, fysiologie, pathologie en optimale mondhygiëne. TvZ/vakblad voor verpleegkundigen 1993;20:659-66.
Velthuizen L, Lugt-Lustig K de, Nieweg R. Vijf protocollen voor mondverzorging. TvZ/vakblad voor verpleegkundigen 1993:21:720-4.
Vissink A, Spijkervet FKL, Stegenga B. Geneesmiddelen bij aandoeningen van mond, gebit en kaak. Geneesmiddelenbulletin 2001;35:119-26.
Xerostomie
Alves MB, Motta AC, Messina WC, Migliari DA. Saliva substitute in xerostomic patients with primary Sjogren’s syndrome: A single-blind trial. Quintessence Int 2004;35:392-6.
Björnström M, Axell T, Birkhed D. Comparison between saliva stimulants and saliva substitutes in patients with symptoms related to dry mouth: A multi-centre study. Swed Dent J 1990;14:153-61.
Davies AN. Management of xerostomia: A review. Eur J Cancer Care 1997;6:209-14.
Davies AN AN, Daniels C, Pugh R, Sharma K. A comparison of artificial saliva and pilocarpine in the management of xerostomia in patients with advanced cancer. Palliat Med 1998;12:105-11.
Davies AN. A comparison of artificial saliva and chewing gum in the management of xerostomia in patients with advanced cancer. Palliat Med 2000;14:197-203.
Davies AN, Broadley K, Beighton D. Xerostomia in patients with advanced cancer. J Pain Symptom Manage 2001;22:820-5.
Dodd MJ, Larson PJ, Dibble SL et al. Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy. Oncol Nurs Forum 1996;23:921-7.
Epstein JB, Emerton S, Le ND, Stevenson-Moore P. A double-blind crossover of Oral Balance gel and Biotene toothpaste versus placebo in patients with xerostomia following radiation therapy. Oral Oncol 1999;35:132-7.
Freer SK. Use of an oral assessment tool to improve practice. Prof Nurse 2000;15:635-7.
Guchelaar HJ, Vermes A, Meerwalt JH. Radiation-induced xerostomia: Pathophysiology, clinical course and supportive treatment. Support Care Cancer 1997;5;281-8.
Hawthorne M, Sullivan K. Pilocarpine for radiation-induced xerostomia in head and neck cancer. Int J Palliat Nurs 2000;l:228-32.
Holmes S. Xerostomia: etiology and management in cancer patients. Support Care Cancer 1998;6:348-355.
Jobbins J. A clinical trial of chlorhexidine oral spray in terminally ill cancer patients. Palliat Med 1992;6:299-307.
Nieuw Amerongen AV, Veerman ECI. Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Support Care Cancer 2003;11:226-31.
Oneschuk D, Hanson J, Bruera E. A survey of mouth pain and dryness in patients with advanced cancer. Support Care Cancer 2000;8:372-6.
Regelink G, Vissink A, Reintsema H, Nauta JM. Efficacy of a synthetic polymer saliva substitute in reducing oral complaints of patients suffering from irradiation-induced xerostomia. Quintessence Int 1998;29:383-6.
Sreebny LM, Valdini A, Yu A. Xerostomia. Part I: relationship to other oral symptoms and salivary gland hypofunction. Oral Surgery, Oral Medicine and Oral Pathology 1988;66:451-8.
Sreebny LM, Valdini A, Yu A. Xerostomia. Part II: relationship to nonoral symptoms, drugs and diseases. Oral Surgery, Oral Medicine and Oral Pathology 1989;68:419-27
Stone P, A’Hern R. Artificial saliva versus pilocarpine for xerostomia. Palliat Med 1999;13:81-2.
Sweeney MP, Bagg J, Baxter WP et al. Clinical trial of a mucin-containing oral spray for treatment of xerostomia in cancer patients. Palliat Med 1997;11:225-32.
Vissink A, ’s-Gravenmade EJ, Panders AK et al. A clinical comparison between commercially available mucin- and CMC-containing saliva substitutes. International Journal of Oral Surgery 1983;12:232-8.
White ID, Hoskin PJ, Hanks GW et al. Morphine and dryness of mouth. BMJ 1989;298:203-7.
Halitosis
Carvalho MD, Tabchoury CM, Cury JA, Toledo S, Nogueira-Filho G. Impact of mouth rinses on morning bad breath in healthy subjects. J Clin Periodontol 2004;21:85-90.
Louis J, Moyer J, Angelini J, et al. Metronidazole oral rinse helps to alleviate odor associated with oral lesions. Oncol Nurs Forum 1997;24:1331.
Ru VJ de, Spronsen R van. Onaangename lichaamsgeuren. III Foetor ex ore. Ned Tijdschr Geneeskd 1986;130:955-7.
Scully C, Porter S, Greenman J. What to do about halitosis. BMJ 1994;308:217-8.
Soder B, Johansson B, Soder PO. The relation between foetor ex ore, oral hygiene and periodontal disease. Swed Dent J 2000;24:73-82.
Winkel EG, Roldan S, Winkelhoff AJ van, et al. Clinical effects of a new mouthrinse containing chlorhexidine, cetylpyridinium chloride and zinc-lactate on oral halitosis. A dual-center, double-blind placebo-controlled study. J Clin Periodontol 2003;30:300-6.
Stomatitis/infectie van de mondholte
Borowski B, Benhamou E, Pico Jl. Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: A randomized controlled trial comparing two protocols of dental care. European Journal of Cancer, Oral Oncology 1994;30B:93-7
Cha R, Sobel JD. Fluconazole for the treatment of candidiasis: 15 year experience. Expert Review of Anti-infective Therapy 2004;2:357-66.
Chiara S, Nobile MT, Vincenti M, et al. Sucralfate in the treatment of chemotherapy-induced stomatitis: A double-blind placebo-controlled trial. Anticancer Res 2001;21:3707-10.
Clarkson JE, Worthington HV, Eden OB. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database of Systematic Reviews 2003, issue 3.
Dodd MJ, Larson PJ, Dibble SL et al. Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy. Oncol Nurs Forum 1996;23:921-7.
Karis K, Kwong F. Prevention and treatment of oropharyngal mucositis following cancer therapy. Cancer Nurs 2004;27:183-205
Loprinzi CL, Ghosh C, Camoriano J et al. Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil-based chemotherapy. J Clin Oncol 1997;15:1235-8.
Meredith R, Saklter M, Kim R et al. Sucralfate for radiation mucositis: Results of a double-blind randomized trial. Int J Radiat Oncol Biol Phys 1997;37:275-9.
Shieh SH, Wang ST, Tsai ST, Tseng CC. Mouth care for nasopharngeal cancer patients undergoing radiotherapy. Oral Oncol 1997;33:93-7.
Trotti A, Bellm LA, Epstein JB et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review. Radiother Oncol 2003; 66: 253-62.
Uitterhoeve RJ. Richtlijn verhoogd risico op beschadigd mondslijmvlies: Richtlijn beschadigd mondslijmvlies. Landelijke Oncologische Verpleegkundige Richtlijnen, patroon 2.4; 2000.
Vissink A, Burlage FR, Spijkervet FKL, et al. Prevention and treatment of the consequences of head and neck radiotherapy. Critical Review of Oral Biology Medicine 2003;14:213-55.
Wothington H, Clarkson JE, Eden OB. Interventions treating oral mucositis for patients with cancer receiving treatment [review]. Cochrane library 2005;(1).
Author information
Authors and Affiliations
Additional information
Mevrouw E.J.M. de Nijs, verpleegkundig specialist palliatieve zorg, umc Utrecht.
E.H. Verhagen, huisarts te Leusden, consulent palliatieve zorg ikmn.
Dit artikel is een bewerking van het hoofdstuk "Klachten van de mond" dat zal verschijnen in Palliatieve zorg, richtlijnen voor de praktijk van de Vereniging van Integrale Kankercentra.
Rights and permissions
About this article
Cite this article
de Nijs, E.J.M., Verhagen, E.H. Mond- en slikklachten in de palliatieve fase. BIJB 21, 314–321 (2005). https://doi.org/10.1007/BF03059874
Issue Date:
DOI: https://doi.org/10.1007/BF03059874